Publikationen in Zusammenarbeit mit Forschern von Dana–Farber Cancer Institute (26)

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

2022

  1. Genomic profiling for clinical decision making in lymphoid neoplasms

    Blood

  2. Hypersensitivity to Pegylated E.colia sparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group

    European Journal of Cancer, Vol. 162, pp. 65-75

2021

  1. Genetic architectures of proximal and distal colorectal cancer are partly distinct

    Gut, Vol. 70, Núm. 7, pp. 1325-1334

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia

    The Lancet Haematology, Vol. 8, Núm. 7, pp. e513-e523

2020

  1. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  2. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 12, pp. 2735-2739

2019

  1. Development and validation of circulating CA125 prediction models in postmenopausal women

    Journal of Ovarian Research, Vol. 12, Núm. 1

  2. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

2018

  1. Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

    The Lancet, Vol. 391, Núm. 10121, pp. 659-667

  2. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1

  3. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Nature Communications, Vol. 9, Núm. 1

2016

  1. Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)

    Carcinogenesis, Vol. 37, Núm. 8, pp. 751-758

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study

    Pediatric Blood and Cancer, Vol. 62, Núm. 12, pp. 2162-2166

  2. Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 21, Núm. 6, pp. 971-983

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2012

  1. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

    Human Molecular Genetics, Vol. 21, Núm. 24, pp. 5373-5384